Minneapolis, Minnesota – A recent report from the Centers for Disease Control and Prevention (CDC) highlights a concerning trend in the opioid crisis, revealing that in 2020, the opioid-related death rate among Black Americans surpassed that of their white counterparts for the first time since the crisis was declared nearly two decades ago.
During 2020 alone, deaths among Black Americans due to opioids surged by 44%, with the death rate nearly doubling for those aged 15 to 24. This troubling increase has sparked discussions among various institutions and experts, including the NYU Grossman School of Medicine, Harvard Medical School, Journal of Racial and Ethnic Health Disparities, and the Substance Abuse and Mental Health Services Administration (SAMSHA).
In Minnesota, data from the Department of Health further emphasizes this disparity, revealing that Black Minnesotans are over three times more likely to die from an “opioid-involved overdose” compared to their white counterparts in the state. Similarly, Indigenous Minnesotans are facing death rates approximately 10 times higher than whites.
Experts point to the influx of fentanyl-laced drugs as a significant factor driving this shift, accounting for over 70,000 deaths annually in the United States. Dr. Ronda Chakolis, president of the Minnesota Board of Pharmacy, raises the question of the adequacy of studies conducted and emphasizes the urgency for implementing strategies and solutions to address these disparities.
Chakolis advocates for a change in language, highlighting the need to differentiate deaths caused by synthetic opioids from those due to prescription opioids. She proposes a comprehensive “poison control model” to tackle the issue, addressing racial disparities in pain management and healthcare access that contribute to the rise in opioid-related deaths among communities of color.
Addressing the systemic barriers faced by people of color in accessing healthcare, Lester Bentley, a mental health clinician in the Twin Cities, emphasizes the importance of equitable treatment, resources, and support for addiction. Bentley calls for a more inclusive approach in addressing substance use, acknowledging the different societal perceptions and stigmas attached to addiction in various communities.
Furthermore, Bentley underscores the need for increased representation of Black medical professionals in the field, pointing to successful models like the Morehouse School of Medicine’s Substance Use, Prevention and Treatment Division and culturally tailored treatment services in different cities across the country. Collaborative efforts between communities and healthcare providers, he argues, are crucial in addressing the complex issues surrounding substance use and addiction.
As the conversation around opioid-related deaths continues, experts like Chakolis and Bentley stress the importance of amplifying culturally competent treatment programs like Turning Point, Inc. in the Twin Cities. By engaging directly with communities and listening to their stories, Chakolis emphasizes the need for tailored interventions that address the unique challenges faced by different populations, particularly among younger generations.
In conclusion, as efforts to address the opioid crisis evolve, a multifaceted approach that addresses systemic disparities, increases diversity in healthcare, and amplifies community voices will be essential in combating the rising death toll from opioid-related overdoses. For more information on programs and services offered by Turning Point, Inc., individuals can visit their website at https://ourturningpoint.org/ or contact the Addiction and Recovery Services Unit in Hennepin County at 612-879-3671.